MX9300433A - Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen. - Google Patents

Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9300433A
MX9300433A MX9300433A MX9300433A MX9300433A MX 9300433 A MX9300433 A MX 9300433A MX 9300433 A MX9300433 A MX 9300433A MX 9300433 A MX9300433 A MX 9300433A MX 9300433 A MX9300433 A MX 9300433A
Authority
MX
Mexico
Prior art keywords
piridincarboximidamine
compounds
pharmaceutical compositions
compositions containing
effect
Prior art date
Application number
MX9300433A
Other languages
English (en)
Inventor
Tomoko Kashiwabara
Soichiro Kaneta
Hideki Okawara
Tatsuo Nakajima
Nobuyuki Ogawa
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of MX9300433A publication Critical patent/MX9300433A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Se describen piridincarboximidamidas, que tienen un afecto vasodilatante (actividad vasodepresora o antiestenocárdica) y sales aductoras de las mismas en donde cuando R1 representa un grupo alquilo, hidroxialquilo, carboxilo, amino, acilamino, alquilamino, dialquilamino, aralquilamino, alquilsulfonamida, bisalquilsulfonilamino, o alquilo, el grupo R2 representa un átomo de hidrógeno y R3 representa un grupo notroxi, 2-clorofenilo o fenilo; y cuando R1 representa un átomo de hidrógeno, R2 representa un grupo alquilo, hidroxialquilo, carboxilo, amino, acilamino, alquilamino, dialquilamino, aralquilamino, alquilsulfonamida, bisalquilsulfonilamino o hidroxilo y R3 representa un grupo nitroxi, 2-clorofenilo o fenilo.
MX9300433A 1992-01-28 1993-01-27 Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen. MX9300433A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1334292 1992-01-28
JP6622192 1992-03-24
JP32576092 1992-12-04

Publications (1)

Publication Number Publication Date
MX9300433A true MX9300433A (es) 1994-07-29

Family

ID=27280214

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300433A MX9300433A (es) 1992-01-28 1993-01-27 Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.

Country Status (18)

Country Link
US (1) US5508293A (es)
EP (1) EP0634400B1 (es)
JP (1) JP2648395B2 (es)
KR (1) KR100249755B1 (es)
CN (1) CN1043760C (es)
AT (1) ATE151073T1 (es)
AU (1) AU674839B2 (es)
CA (1) CA2129013C (es)
DE (1) DE69309454T2 (es)
DK (1) DK0634400T3 (es)
ES (1) ES2100522T3 (es)
FI (1) FI105399B (es)
HK (1) HK1000094A1 (es)
HU (1) HU218487B (es)
MX (1) MX9300433A (es)
NO (1) NO302070B1 (es)
TW (1) TW232009B (es)
WO (1) WO1993015057A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
AU6016496A (en) * 1995-06-14 1997-01-15 Sankyo Company Limited Antianginal drug comprising nitroxy derivative as active ingredient
WO1998035673A1 (fr) * 1997-02-14 1998-08-20 Kirin Beer Kabushiki Kaisha Medicaments utilises dans la decongestion du flux sanguin peripherique
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
JP2003321329A (ja) * 2002-04-25 2003-11-11 Kirin Brewery Co Ltd 育毛剤
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
JP2007525165A (ja) 2003-03-07 2007-09-06 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク タイプ１ライアノジン受容体に基づく方法
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
TW200908984A (en) * 2007-08-07 2009-03-01 Piramal Life Sciences Ltd Pyridyl derivatives, their preparation and use
EP3088390A1 (en) 2015-04-30 2016-11-02 Bayer CropScience AG Catalytic hydrogenation of substituted cyanopyridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662567B2 (ja) * 1988-12-27 1994-08-17 麒麟麦酒株式会社 ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途
FI95244C (fi) * 1988-12-27 1996-01-10 Kirin Brewery Analogiamenetelmä valmistaa lääkeaineina käyttökelpoisia uusia karboksimidiamidijohdannaisia tai niiden farmaseuttisesti sopivia happoadditiosuoloja
JP2846070B2 (ja) * 1989-11-29 1999-01-13 麒麟麦酒株式会社 カルボキシイミダミド誘導体

Also Published As

Publication number Publication date
DE69309454T2 (de) 1997-08-14
CA2129013C (en) 2001-08-14
NO302070B1 (no) 1998-01-19
DK0634400T3 (da) 1997-04-28
EP0634400B1 (en) 1997-04-02
CN1077949A (zh) 1993-11-03
CA2129013A1 (en) 1993-07-29
EP0634400A1 (en) 1995-01-18
KR100249755B1 (ko) 2000-04-01
NO942740L (no) 1994-09-27
AU674839B2 (en) 1997-01-16
HU9402218D0 (en) 1994-09-28
HU218487B (hu) 2000-09-28
WO1993015057A1 (en) 1993-08-05
AU3367793A (en) 1993-09-01
HK1000094A1 (en) 1997-11-21
US5508293A (en) 1996-04-16
EP0634400A4 (en) 1995-06-14
KR950700255A (ko) 1995-01-16
HUT70506A (en) 1995-10-30
FI943508A0 (fi) 1994-07-26
TW232009B (es) 1994-10-11
ES2100522T3 (es) 1997-06-16
CN1043760C (zh) 1999-06-23
FI943508A (fi) 1994-09-22
JP2648395B2 (ja) 1997-08-27
DE69309454D1 (de) 1997-05-07
FI105399B (fi) 2000-08-15
NO942740D0 (no) 1994-07-22
ATE151073T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
MX9300433A (es) Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
IL148516A (en) Retroviral protease inhibiting compound
SE8503888D0 (sv) Heterocykliska derivat
SE9203825D0 (sv) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
FI931067A (fi) Antitumoera foereningar
IE850140L (en) Methylenediphosphonic acid derivatives antirheumatic agents
DE69326479D1 (de) Methotrexat-derivate
ES8307252A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido clavulanico.
ES2036613T3 (es) Fungicidas que contienen aminocompuestos.
DK0614891T3 (da) Fremgangsmåde til fremstilling af 2-substituerede 5-chlorimidazol-4-carbaldehyder
DK551487D0 (da) 1-hydroxyalkylxanthiner samt farmaceutiske praeparater med indhold af saadanne forbindelser
SE8001620L (sv) Merkaptoacylderivat av ketosubstituerad prolin- och pipekolinsyra

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees